ResMed's second-quarter results, released on January 30, 2025, demonstrated strong financial health, with a 10% year-over-year (YoY) increase in revenue and a significant improvement in gross ...

Learn More ResMed Inc (ASX: RMD) shares are in the red so far in 2025. After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...